Skip to content
naulon
Not checkedNot checked for notices yet.

Flecainide treats a novel KCNJ2 mutation associated with Andersen-Tawil syndrome

Hanora A. Van Ert, BSN, Elise C. McCune, Kate M. Orland, MS and 4 more

HeartRhythm Case Reports · 2017

doi:10.1016/j.hrcr.2016.11.009 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

KCNJ2 encodes for the potassium inward rectifier channel protein Kir2.1, and mutations in KCNJ2 are associated with various inherited arrhythmia syndromes, such as Andersen-Tawil syndrome type 1 (ATS1), short QT syndrome 3, familial atrial fibrillation, and catecholaminergic polymorphic ventricular tachycardia 3.1–5 ATS1 is an autosomal dominant inherited disease with a multisystem phenotype consisting of periodic paralysis, ventricular arrhythmias, and craniofacial dysmorphic features.6 Ventricular arrhythmias can include frequent ventricular ectopy, bigeminy, polymorphic ventricular tachycardia (VT), and, less commonly, bidirectional VT.

Abstract licence: CC BY-NC-ND

References21

    21 more references, whose wording the paper’s licence keeps private.

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.